News
InflaRx gains European Commission approval for GOHIBIC to treat SARS-CoV-2-induced acute respiratory distress syndrome
The European Commission (EC) has granted marketing authorization under exceptional circumstances for InflaRx's GOHIBIC (vilobelimab) for the treatment of adult patients with SARS-CoV-2-induced acute...
Lyndra forms strategic clinical research and commercial manufacturing services collaboration with Thermo Fisher for...
Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, has entered a strategic collaboration with Thermo Fisher Scientific, in which Thermo Fisher will...
Formycon and Fresenius Kabi secure MHRA approval for Stelara biosimilar
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for Fresenius Kabi and Formycon's ustekinumab biosimilar candidate, indicated for the...
